Please login to the form below

Not currently logged in
Email:
Password:

Repositive

This page shows the latest Repositive news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca embarks on oncology research access project

AstraZeneca embarks on oncology research access project

AstraZeneca will contribute its expertise in oncology to the platform, while Repositive's work to develop tools for accessing human genomic data will be used to create the resource. ... Users of the Repositive platform can quickly and easily access human

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Repositive appoints scientific lead Repositive appoints scientific lead

    Manuel Corpas joins the genome software company. Cambridge, UK-based Repositive has appointed Manuel Corpas as its scientific lead. ... In his new role, Corpas will be responsible for building awareness in the scientific community around Repositive's

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...